+

WO2001028979A3 - Inhibiteurs des neuraminidases - Google Patents

Inhibiteurs des neuraminidases Download PDF

Info

Publication number
WO2001028979A3
WO2001028979A3 PCT/US2000/027938 US0027938W WO0128979A3 WO 2001028979 A3 WO2001028979 A3 WO 2001028979A3 US 0027938 W US0027938 W US 0027938W WO 0128979 A3 WO0128979 A3 WO 0128979A3
Authority
WO
WIPO (PCT)
Prior art keywords
neuraminidases
compounds
processes
disclosed
inhibitors
Prior art date
Application number
PCT/US2000/027938
Other languages
English (en)
Other versions
WO2001028979A2 (fr
Inventor
Clarence J Maring
Vincent L Giranda
Dale J Kempf
Vincent S Stoll
Minghua Sun
Chen Zhao
Yu Gui Gu
Gary T Wang
Allan C Krueger
Yuanwei Chen
David A Degoey
David J Grampovnik
Warren M Kati
April L Kennedy
Zhen Lin
Donald L Madigan
Steven W Muchmore
Hing L Sham
Kent D Stewart
Sheldon Wang
Ming C Yeung
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Priority to AU80051/00A priority Critical patent/AU8005100A/en
Publication of WO2001028979A2 publication Critical patent/WO2001028979A2/fr
Publication of WO2001028979A3 publication Critical patent/WO2001028979A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/48—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés représentés par la formule (I), (II) ou (III) utiles pour inhiber les neuraminidases de micro-organismes pathogènes, tout particulièrement, les neuraminidases de l'influenza. L'invention concerne également des compositions et des procédés destinés à la prévention et au traitement de maladies causées par des micro-organismes renfermant une neuraminidase, des procédés de préparation des composés et des intermédiaires synthétiques utilisés dans ce procédé.
PCT/US2000/027938 1999-10-19 2000-10-10 Inhibiteurs des neuraminidases WO2001028979A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU80051/00A AU8005100A (en) 1999-10-19 2000-10-10 Inhibitors of neuraminidases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/422,093 1999-10-19
US09/422,093 US6518305B1 (en) 1998-04-23 1999-10-19 Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases

Publications (2)

Publication Number Publication Date
WO2001028979A2 WO2001028979A2 (fr) 2001-04-26
WO2001028979A3 true WO2001028979A3 (fr) 2001-12-27

Family

ID=23673358

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/027938 WO2001028979A2 (fr) 1999-10-19 2000-10-10 Inhibiteurs des neuraminidases

Country Status (4)

Country Link
US (1) US6518305B1 (fr)
AU (1) AU8005100A (fr)
CO (1) CO5271741A1 (fr)
WO (1) WO2001028979A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SV2003000617A (es) * 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
FR2874014B1 (fr) * 2004-08-03 2010-05-14 Univ Paris Descartes Analogues d'aminoglycosides, leur utilisation et leur synthese
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
CA2744947A1 (fr) * 2008-12-19 2010-10-28 The Regents Of The University Of California Utilisation d'inhibiteurs du facteur de croissance epidermique dans le cadre du traitement d'une infection virale
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
CN106496153B (zh) * 2016-09-07 2018-07-10 上海应用技术大学 一种1，3-恶唑-2-硫酮类神经氨酸酶抑制剂及其制备方法
WO2020205867A1 (fr) 2019-04-02 2020-10-08 Aligos Therapeutics, Inc. Composés ciblant prmt5

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997047194A1 (fr) * 1996-06-14 1997-12-18 Biocryst Pharmaceuticals, Inc. Composes cyclopentane substitues convenant comme inhibiteurs des neuraminidases
WO1999033781A1 (fr) * 1997-12-17 1999-07-08 Biocryst Pharmaceuticals, Inc. Composes des cyclopentane et cyclopentene convenant comme inhibiteurs de neuraminidase
WO1999054290A1 (fr) * 1998-04-23 1999-10-28 Abbott Laboratories Inhibiteurs de neuraminidases

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB229081A (en) 1924-02-06 1925-02-19 James Nicholson Hill Improvements in or connected with kettles, saucepans, water heaters, and the like
SK282950B6 (sk) 1990-04-24 2003-01-09 Biota Scientific Management Pty Ltd Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze
WO1992006691A1 (fr) 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Composes anti-viraux qui lient le site actif de la neuraminidase de la grippe et presentent une activite in vivo contre l'orthomixovirus et le paramyxovirus
DE4035961A1 (de) 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
AU659501B2 (en) 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
GB9400206D0 (en) 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5453533A (en) 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
US5512596A (en) 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
BR9607098A (pt) 1995-02-27 1997-11-04 Gilead Sciences Inc Novos inibidores seletivos de neuraminidas virais ou bacterianas
US5602277A (en) 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
JP4162712B2 (ja) 1995-05-19 2008-10-08 バイオタ、サイアンティフィック、マネージメント、プロプライエタリ、リミテッド ６−カルボキサミドジヒドロピラン誘導体
GB9516276D0 (en) 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
US5763483A (en) 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
KR19990087449A (ko) 1996-03-01 1999-12-27 리차드 웨드레이 인플루엔자 바이러스의 검출방법 및 이에 이용되는 화합물
ATE211468T1 (de) 1996-07-22 2002-01-15 Sankyo Co Neuraminsäuredervate, ihre herstellung und medizinische verwendung
US5821243A (en) 1996-07-22 1998-10-13 Viropharma Incorporated Compounds compositions and methods for treating influenza
KR100526666B1 (ko) 1996-08-13 2005-11-08 상꾜 가부시키가이샤 뉴라민산 화합물
DE69711395T2 (de) 1996-08-23 2002-11-07 Gilead Sciences, Inc. Verfahren zur herstellung von cyclohexen-carboxylatderivate
WO1998011083A1 (fr) 1996-09-10 1998-03-19 Daikin Industries, Ltd. Acides sialiques 2,7-dideoxy-7-fluoro- 2, 3-didehydro a quadruple substitution
CN1238762A (zh) 1996-10-21 1999-12-15 吉里德科学公司 哌啶化合物
JP3691075B2 (ja) 1996-11-14 2005-08-31 バイオタ、サイアンティフィック、マネージメント、プロプライエタリ、リミテッド 新規化合物およびその使用方法
WO1999006369A1 (fr) 1997-08-01 1999-02-11 University Of Florida Inhibiteurs de neuraminidase
ID25516A (id) 1997-09-17 2000-10-05 Gilead Sciences Inc Senyawa-senyawa yang mengandung cincin-cincin beranggotakan enam, proses pembuatannya, dan penggunaannya sebagai obat
ZA988469B (en) 1997-09-17 1999-03-17 Biocryst Pharm Inc Pyrrolidin-2-one compounds and their use as neuraminidase inhibitors
TW477783B (en) 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997047194A1 (fr) * 1996-06-14 1997-12-18 Biocryst Pharmaceuticals, Inc. Composes cyclopentane substitues convenant comme inhibiteurs des neuraminidases
WO1999033781A1 (fr) * 1997-12-17 1999-07-08 Biocryst Pharmaceuticals, Inc. Composes des cyclopentane et cyclopentene convenant comme inhibiteurs de neuraminidase
WO1999054290A1 (fr) * 1998-04-23 1999-10-28 Abbott Laboratories Inhibiteurs de neuraminidases

Also Published As

Publication number Publication date
US6518305B1 (en) 2003-02-11
AU8005100A (en) 2001-04-30
CO5271741A1 (es) 2003-04-30
WO2001028979A2 (fr) 2001-04-26

Similar Documents

Publication Publication Date Title
WO2001028996A3 (fr) Inhibiteurs de neuraminidases
WO2006073973A3 (fr) Nouveaux dérivés de benzylamine en tant qu'inhibiteurs de cetp
CA2367017A1 (fr) Inhibiteurs de l'enzyme impdh
CA2441313A1 (fr) Nouveaux derives spirotricycliques et leur utilisation en tant qu'inhibiteurs de la phosphodiesterase-7
WO2004074244A3 (fr) Composes de pyrimidine
WO2004009559A3 (fr) Composes de dihydro-uracile utilises comme agents anti-ictogenes ou anti-epileptogenes
WO2007059230A3 (fr) 1h-benzimidazole-4-carboxamides substitues efficaces en tant qu’inhibiteurs de parp
HK1159614A1 (en) Caspase inhibitors and uses thereof
WO2005021497A3 (fr) Trimeres et dimeres fixes de 1,4-diphenylazetidin-2-ones
BRPI0410669A (pt) inibidores de caspase e usos dos mesmo
NZ502988A (en) 5-Acetamido-4-amino-2-propionyloxy-6-isopropoxy-1-cyclohexene useful for treating influenza
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
AP1766A (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases
WO2001028979A3 (fr) Inhibiteurs des neuraminidases
WO2004033423A3 (fr) Composes anticancer
WO2001000577A3 (fr) Preparation de piperidine-4-ones substituees
YU101402A (sh) Visoko prečišćeni preparati simvastatina
WO2003072063A3 (fr) Sulfonanilides a substitution amino et leurs derives, destines au traitement de troubles proliferatifs
PT1102765E (pt) Processo para a sintese de derivados de (1h)-benzo¬c|quinolizin-3-onas
MY129094A (en) Condensed polycyclic compounds
WO2004060878A3 (fr) Inhibiteurs de phosphatases
WO2001083423A3 (fr) Acide 2,6-diamino-6-methyl-heptanoique et derives, procede de preparation et utilisation correspondants
WO2002102369A3 (fr) Agent de protection des neurones retiniennes
WO2002010124A3 (fr) Sels d'un inhibiteur de la protease du vih

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

ENPW Started to enter national phase and was withdrawn or failed for other reasons

Ref document number: PI0010554

Country of ref document: BR

Free format text: PEDIDO CONSIDERADO RETIRADO EM RELACAO AO BRASIL, POR TER SIDO A FASE NACIONAL INTEMPESTIVA.

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载